ArticleCancer management and research2018

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis.

Yi Que et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.